ArTS Archivio della ricerca di Trieste

MUSTACCHI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.686
NA - Nord America 4.426
AS - Asia 721
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 13
AF - Africa 3
OC - Oceania 3
Totale 26.872
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.503
US - Stati Uniti d'America 4.416
UA - Ucraina 386
FR - Francia 358
SE - Svezia 319
SG - Singapore 302
GB - Regno Unito 182
CN - Cina 167
DE - Germania 164
CH - Svizzera 155
FI - Finlandia 121
HK - Hong Kong 110
RU - Federazione Russa 68
TR - Turchia 68
IE - Irlanda 64
NL - Olanda 64
BG - Bulgaria 62
PL - Polonia 43
RO - Romania 37
ES - Italia 30
AL - Albania 28
IN - India 24
BE - Belgio 22
EU - Europa 20
IR - Iran 14
DK - Danimarca 12
PT - Portogallo 12
GR - Grecia 11
BR - Brasile 9
CZ - Repubblica Ceca 9
MY - Malesia 9
AT - Austria 8
CA - Canada 8
IL - Israele 6
SI - Slovenia 6
SM - San Marino 6
HR - Croazia 4
LU - Lussemburgo 4
SA - Arabia Saudita 4
CL - Cile 3
JP - Giappone 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
GE - Georgia 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
VN - Vietnam 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CF - Repubblica Centrafricana 1
EG - Egitto 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
LB - Libano 1
MX - Messico 1
NO - Norvegia 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 26.872
Salva come PNG Salva come JPEG
Città #
Rome 1.074
Milan 1.018
Woodbridge 538
Ann Arbor 424
Fairfield 379
Jacksonville 340
Houston 330
Chandler 320
Naples 301
Singapore 275
Ashburn 230
Wilmington 218
Florence 211
Turin 185
Seattle 182
Bologna 177
Palermo 156
Padova 154
Trieste 146
Napoli 138
Cambridge 132
Princeton 118
Boardman 113
Torino 109
Bari 108
Hong Kong 108
Catania 96
Genoa 93
Brescia 88
Santa Clara 77
Dallas 71
Cagliari 68
Verona 66
Columbus 61
Dublin 59
Sofia 59
Perugia 58
Izmir 57
Bergamo 54
Monza 44
Moscow 44
Caserta 43
Beijing 42
Messina 42
Genova 41
Mountain View 41
Pescara 41
Udine 41
Como 40
Venezia 37
Dearborn 36
Reggio Calabria 36
Treviso 35
Vicenza 33
Sassari 32
Modena 30
Pisa 30
Ancona 29
Lucca 29
Taranto 29
Latina 28
San Diego 28
Reggio Nell'emilia 26
Catanzaro 25
Parma 25
Livorno 24
Pavia 23
Prato 23
Salerno 23
Venice 23
Bremen 22
Foggia 22
Redwood City 22
Novara 21
Siena 20
Ferrara 19
Trento 19
Abbiategrasso 18
Legnano 18
Mestre 18
Redmond 18
Mumbai 17
Ravenna 17
Duino-Aurisina 16
Rimini 16
Torre Del Greco 16
Bolzano 15
Reggio Emilia 15
Busto Arsizio 14
Dalmine 14
Lugano 14
Quartu Sant'elena 14
Rende 14
San Mateo 14
Scafati 14
Alessandria 13
Asti 13
Bacoli 13
Brussels 13
Buffalo 13
Totale 9.906
Salva come PNG Salva come JPEG
Nome #
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico 20.957
Advances in systemic therapy for metastatic breast cancer: future perspectives 323
Prognostic-predictive factors in breast cancer: comparison of mRNA level (Target Print) and immunohistochemistry expression 188
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 178
Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach. 178
Breast cancer in elderly women: a different reality? Results from the NORA Study 153
Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial 151
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study. 148
Adjuvant systemic treatment of early breast cancer: The NORA study. 144
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study 144
Role of lifestyles in breast cancer risk: a retrospective analysis of Trieste's female population 137
Gene expression profiling in breast cancer: A clinical perspective 134
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. 133
A Phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer. 127
The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database 127
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancerdeath: meta-analysis of individual patient data for 10,801 women in 17 randomised trials 126
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 124
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study 122
Tamoxifen versus surgery plus Tamoxifen as primary treatment for elderly patients with breast cancer: combined data from the “GRETA” and “CRC” trials 121
Psychological Response to Cancer: Role of 5-HTTLPR Genetic Polymorphism of Serotonin Transporter 120
Early detection of breast cancer recurrences through periodic follow up - Is it useless? 117
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. 116
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study. 115
Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer 115
Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study. 108
Sequential Tamoxifen and Aminoglutethimide Versus Tamoxifen Alone in the Adjuvant Treatment of Postmenopausal Breast cancer Patients: Results of an Italian Cooperative Study 103
Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs 101
La metanalisi di Oxford del 2000: riflessioni e commenti 98
An induction dose of epoietin alpha of 40.000 IU daily for three consecutive days increases and mantains hemoglobin levels in anemic cancer patients undergoing chemotherapy. 98
Molecular targets of cancer chemotherapy 97
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study 97
Annual Hazard Rates of Recurrence for early breast cancer. What has changed in the last 10 years? Results from the NORA study. 96
ITALIAN BREAST CANCER ADJUVANT CHEMO-HORMONE THERAPY COOPERATIVE GROUP TRIALS 95
Cancro del fegato: possibilità di diagnosi precoce 94
Changes in adjuvant treatment of early breast cancer in Italy between 2000 and 2008. The NEMESI study versus the NORA study. 94
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 7 years of the 1st GROCTA Trial. 90
Effectiveness of magnetotheraphy in resolution of some early complications of the mastectomy operation. 90
Gli antidoti in Oncologia medica: efficacia, costo e beneficio 89
A multicentre, double blind, randomised trial comparing ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 89
Modulating effect of Lonidamine on Response to Doxorubicin in Metastatic Breast cancer patients: Results from a Multicenter Prospective Randomized Trial. 88
Il Carcinoma del Fegato: Realtà e Prospettive Epidemiologia 87
Carcinoma dell’ovaio 85
Un programme de réhabilitation chez la femme mastectomisée 81
The combination of Metoclopramide, Methylprednisolone and Ondansetron against antiblastic - delayed emesis: a randomised Phase II study. 80
Extragonadal Germ Cell Tumor: a Clinical Stdy. 78
Prevention of chemotherapy-induced early menopause in early breast cancer patients. A phase III multicenter study of GIM Group 78
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 8 years of the first GROCTA (Italian Cooperative Group for Adjuvant Chemo-Hormonal Therapy of Breast cancer)Trial. 71
La communication du diagnostic de cancer 71
Ovarian function in premenopausal women affected by breast cancer: the measurement of glucuronoconjugate metabolites of 17-beta-estradiol and progesterone throughout one entire menstrual cycle 67
Relapse rate after adjuvant trastuzumab in the northeast of Italy: Preliminary data from a multicenter observational study in a clinical setting. J Clin Oncol 30, 2012 (suppl; abstr 586) 66
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]] 66
Effect of menstrual status on response to adjuvant chemotherapy and /or endocrine therapy. 63
Observer variations in mammary thermography: results of a teaching file test carried out in four different centers 58
Tamoxifen or Surgery plus Tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial 58
Factors influencing the switch from tamoxifen to aromatase inhibitors as adjuvant therapy in early breast cancer patients. Results from the NORA Study 55
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials. 54
Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long term results of the phase III randomized controlled multicenter “GRETA” trial. 53
Prolonged Tamoxifen Treatment of Early Breast Cancer: The experience of the Italian Cooperative Group for Chemo-Hormonal Therapy of Early Breast Cancer. 52
Role of erythropoietin in the oncology patient: critical review of the literature 49
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 36
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 34
Totale 27.167
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.780
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.491 0 0 0 0 0 593 530 498 256 192 244 178
2020/20212.813 281 286 258 311 196 227 171 214 226 253 185 205
2021/20221.895 112 142 124 154 121 95 101 110 211 171 169 385
2022/20234.469 323 320 351 347 367 472 293 369 427 284 451 465
2023/20243.525 447 401 315 332 273 185 351 326 76 289 283 247
2024/20251.689 274 286 485 246 235 163 0 0 0 0 0 0
Totale 27.167